What is Corvus Pharmaceuticals's net investment in lease?

Corvus Pharmaceuticals (CRVS) reported net investment in lease of $751K in Q1 2026.

How has Corvus Pharmaceuticals's net investment in lease changed year-over-year?

Corvus Pharmaceuticals's net investment in lease decreased by 31.4% year-over-year, from $1.1M to $751K.

What is the long-term trend for Corvus Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Corvus Pharmaceuticals's net investment in lease has grown at a -12.6% compound annual growth rate (CAGR), from $1.65M to $839K.

Corvus Pharmaceuticals CRVS Net Investment in Lease

Net Investment in Lease at other companies

Avalo TherapeuticsAVTX

——

Cullinan Therapeutics, Inc.CGEM

——

Iovance Biotherapeutics, Inc.IOVA

——

Vor BiopharmaVOR

——

Protagonist TherapeuticsPTGX

——

Kymera TherapeuticsKYMR

——

Other financials

Income statement

See full

Operating income-$14.9M-49.9%

Net income-$13.7M-190%

EPS (diluted)-$0.15-15.4%

Balance sheet

See full

Cash & equivalents$40.1M+702%

Total debt$834.0K-27.7%

Total equity$240.7M+388%

Total assets$253.2M+326%

Cash flow

See full

Operating cash flow-$10.4M-25.5%

CapEx$91.0K+153%

Free cash flow-$10.5M-26.1%

Valuation

See full

Market cap$1.09B+259%

Enterprise value$1.05B+251%

Returns & leverage

See full

Return on equity-30.5%-12.5pp

Debt / equity0×0.0×

Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvus Pharmaceuticals's net investment in lease?: Corvus Pharmaceuticals (CRVS) reported net investment in lease of $751K in Q1 2026.
How has Corvus Pharmaceuticals's net investment in lease changed year-over-year?: Corvus Pharmaceuticals's net investment in lease decreased by 31.4% year-over-year, from $1.1M to $751K.
What is the long-term trend for Corvus Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Corvus Pharmaceuticals's net investment in lease has grown at a -12.6% compound annual growth rate (CAGR), from $1.65M to $839K.